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Toll-like receptorendritic cells (mDC and pDC) are naturally distinctive subsets. We exposed both
subsets to dengue virus (DV) in vitro and investigated their functional characteristics. High levels of DV
replication in mDC were found to correlate with DC-SIGN expression. Production of inﬂammatory cytokines
by mDC increased gradually after DV-infection, which was dependent on DV replication. Co-stimulatory
markers were upregulated on mDC upon DV-infection. On the contrary, lower levels of DV-replication were
observed in pDC, but the cytokine production in pDC was quicker and stronger. This cytokine response was
not dependent on viral replication, but dependent on cell endosomal activity and TLR7, and could be also
induced by puriﬁed DV genome RNA. These results clearly suggested functional differences between mDC
and pDC in response to DV infection. Additionally, the TLR7-mediated recognition of DV RNA may be involved
in pDC functional activation.
© 2008 Elsevier Inc. All rights reserved.Introduction
Human peripheral blood contains two precursors of dendritic
cells (DC): plasmacytoid DC (pDC) precursors and myeloid DC (mDCs)
precursors bearing distinctive surface marker, Lin1−CD11c−CD123high
and (Lin1−CD11c+CD14−CD123med, respectively. In addition, mono-
cytes (CD11c+CD14+)are also considered precursors of myeloid DC (Liu
et al., 2005). Originated from CD34+ progenitors in bone marrow,
precursors of pDC undergo maturation in response to interleukine
(IL)-3 plus CD40 ligand (CD40L) or IL-3 alone, whereas mDC and
monocytes depend on GM-CSF and IL-4 to differentiate into immature
DC and undergo furthermaturationwith inﬂammatory stimuli such as
TNF-α and CD40L. Dendritic cells of pDC lineage are distributed in T
cell-rich areas of the secondary lymphoid tissues and the mucosa-
associated lymphoid tissues, while cells of mDC lineage in non-
lymphoid tissues and the T cell-rich areas of secondary LN. Freshly
isolated mDC acquire a typical DC morphology distinguishable bymber 61102A.870.S.A0015. The
d do not necessarily reﬂect the
epartment of Defense, nor the
l rights reserved.dendrites during in vitro culturing, and can capture, process and
present antigens to T cells, thus are important in bridging the innate
and adaptive immune systems. On the other hand, pDC lack
phagocytic capacity, and are less efﬁcient in capturing and presenting
antigens to T cells. However, pDC are well known as type-I IFN
producing cells (Liu, 2005), capable of producing 100–1000 times
more IFN-α than any other blood cell type in the presence of viruses or
bacteria (Siegal et al., 1999), and are thus considered to play a crucial
role in anti-viral immunity.
Dengue virus (DV) is a single-stranded RNA virus belonging to
genus Flavivirus that causes febrile illnesses ranging from mild
dengue fever (DF), to severe dengue hemorrhagic fever (DHF) and
dengue shock symptom (DSS) (Gubler, 1998). Recently, the participa-
tion of mDC and pDC during acute DV infection was reported by
Pichyangkul et al. (2003). The study showed that a decrease in the
number of mDC and pDC in the circulating peripheral blood during
acute infection correlates with an increase in disease severity.
Further, the role of myeloid DC as target cells for DV infection has
been demonstrated previously with in vitro monocyte-derived DC in
a number of studies and with dermal DC derived from biopsy
samples of a dengue patient (Marovich et al., 2001; Wu et al., 2000).
Infection appears to be dependent on the surface expression of DC-
SIGN, a glycan–protein of C-type lectin (Navarro-Sanchez et al.,
2003; Tassaneetrithep et al., 2003). Infected DC produce TNF-α, IFN-
208 P. Sun et al. / Virology 383 (2009) 207–215α and other cytokines (Libraty et al., 2001; Palmer et al., 2005). It is
unclear to us the molecular mechanisms involved in activation of
DV-exposed mDC and pDC leading to production of inﬂammatory
cytokines.
One of the important features of the innate immune response is
recognition of pathogen-associated pattern molecules through Toll-
like receptors (TLR), resulting in cell activation and cytokine produc-
tion. Among 11 TLR currently known, TLR3 and TLR7 have been
demonstrated to be expressed intracellularly in mDC and pDC
(Matsumoto et al., 2003; Nishiya et al., 2005), respectively. Both
TLR3 and TLR7 have been shown to recognize RNA viruses such as
inﬂuenza virus (Diebold et al., 2004; Guillot et al., 2005; Lund et al.,
2004), respiratory syncytial virus (RSV) (Groskreutz et al., 2006), and
vesicular stomatitis virus (VSV) (Lund et al., 2004). TLR7 recognizes
single-stranded RNA (ssRNA), while TLR3 recognizes double-stranded
RNA (dsRNA). Being a single stranded RNA virus, DV may activate cells
through TLR-dependent pathways.
In this study, we used pDC and mDC derived directly from
peripheral blood mononuclear cells (PBMC) by immuno-magnetic
sorting and compared their functional characteristics upon DV-
infection, including the involvement of TLRs. Our results showed a
number of differences between mDC and pDC, the former hosted
higher levels of DV replication, but slow and lower in cytokine
response while the latter poorly supported DV replication but quick
and more vigorous in cytokine production. In addition, TLR7 is likely
involved in the recognition of DV for the cytokine production, whereas
the role of TLR3 remains unclear.Fig. 1. Phenotype of freshly isolated mDC and pDC. Histogram analysis of ﬂow cytometry sh
staining is shown in ﬁlled peaks, while staining of indicated surface markers is shown in opResults
Phenotype of freshly isolated mDC and pDC
pDC and mDC each comprises about 0.5% of human PBMC. Due to
the differential expression of cell surfacemarkers, bloodmDC and pDC
can be selectively isolated and distinguished. We isolated cell subsets
that were either showing mDC phenotype CD11c+/CD123intermediate or
pDC phenotype CD11c−/CD123high (Fig. 1a). Both subsets belonged to
Lin1− (CD3, CD14, CD16, CD19, CD20, CD56) population. We further
examined co-stimulatory markers and HLA (Fig. 1b). Both mDC and
pDC expressed high levels of MHC class I (HLA-ABC) and class II (DR),
modest levels of CD40 and CD86, and undetectable levels of CD80 and
CD83. As co-stimulatory molecules mark DC maturation, low expres-
sion of these markers indicated an immature stage of DC develop-
ment. DC-SIGN, a molecule commonly accepted as DV receptor, was
not detected using CD209 MAb on the cell surface of either subset.
DV infection in mDC and pDC
DV infection of target cells was measured by a FITC-conjugated
anti-viral prMmonoclonal antibody 2H2, and byWestern blot analysis
using anti-DV-2 immune ascites ﬂuid. Freshly isolated mDC and pDC
lost viability rapidly ex vivo (both about 50% viability at 48 h post-
isolation) and we were unable to detect prM expression in either cell
subsets (data not shown). The combination of rGM-CSF and rIL-4
improved mDC survival (N90%), and additionally induced DC-SIGNows the intensity of expression of surface markers as labeled. Isotype control antibody
en peaks. Data represent 3 experiments.
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DC-SIGN, infection increased in mDC (Figs. 2b, c). DC-SIGN levels and
infection rates ﬂuctuated among individuals, however, in seven
individual donor mDC we tested, a positive correlation between DC-
SIGN and infection rates was observed and the correlation coefﬁcient
(CORREL) is 0.859 (Fig. 2c). Western blot analysis using anti-DV-2
immune ascites ﬂuid further conﬁrmed expression of viral proteins in
cytokine-pretreated mDC (Fig. 2d). In contrast, although the viability
of rIL-3-supplemented pDC (N90%) was comparable to that of mDC,
neither immuno-ﬂuorescent staining nor immuno-blotting detected
viral antigens in pDC (Figs. 2b, d). In summary, we observed an average
infection rate in mDC of 34.3% with a SEM of 6.7; while infections in
pDC were nearly undetectable by antibodies. We further measured
infection by quantifying the negative sensed RNA strands using RT-
PCR. While both cell subsets showed the presence of negative sensed
strands of DV, the amount of negative strands in pDC were 2–3 logs
lower than that in mDC (Fig. 2e). The results suggested that pDC are
also capable to internalize DV, but are poorly supportive for viral
replication.
Cytokine response and cell maturation
Both pDC and mDC produced IFN-α, TNF-α and IL-6 in response to
DV exposure (Fig. 3a). Neither subset produced IL-12 or IL-1β (data
not shown). Cytokines produced by pDC peaked at 24 h, whereas
cytokines produced by mDC showed a gradual increase from 24 to
48 h. Comparing TNF and IFN levels between pDCs and mDCs, the
former elicited a quicker response with markedly higher amounts of
cytokines (about 10 fold higher). We randomly performed the
viability check of mDC and pDC at 48 h post-DV exposure. We did
not ﬁndmassive cell death of mDC (about 90% viability, comparable toFig. 2. Infection in mDC and pDC. (a) Histogram analysis of CD209 expression on cytokine-t
determined by 2H2 staining at 48 h post-viral exposure. Data represent 3 experiments. (c) Co
donors. The correlation coefﬁcient (CORREL) was shown. (d) Infection determined by We
quantiﬁcation of negative sense RNA. Data showed the increase of the negative sense RNA at
subtracted). Mock control showed 0 copy number. Data represent 3 experiments.that of pDC). Therefore, the difference in cytokine levels is unlikely
due to cell death. We also examined the co-stimulatory markers on
mDC and pDC (Fig. 3b) to measure cell maturation. Comparing with
freshly isolated mDC and pDC in Fig. 1b, increased expression of CD40,
CD80, CD83, and CD86 was seen on mDC and pDC cultured with
cytokines alone, which is consistent with earlier publications
(Grouard et al., 1997). After DV infection, there is a further
upregulation of these surface markers on mDC, but not on pDC.
These results showed functional differences between mDC and pDC in
response to DV activation.
UV-attenuated DV in DC subsets activation
We continued to ask if DV-replication is critical in DC subset
activation. We attenuated DV using UV. Reduction of DV infectivity
after treatment with escalating doses of UV was assessed in Vero cell
infection experiments. The 200,000 μJ was chosen from a series of UV
doses tested. At 200,000 μJ, there was a 95% reduction in infectivity for
UV-treated DV in Vero cells. Similar level of reduction in mDC was
observed (data not shown). In relation to the reduction of infectivity,
IFN-α production in mDC to UV-attenuated DV was diminished
completely. On the other hand, 200,000 μJ UV irradiation of DV had a
limited effect on pDC for IFN-α production (Fig. 4b). These results
indicate that viral replication is important for mDC, but not for pDC
cell activation.
Requirement of endosomal acidiﬁcation
We further examined the involvement of endosomal activity in
pDC activation. We used the chloroquine, a weak base chemical, to
neutralize the acidic environment of endosomes. Chloroquine showedreated mDC: ﬁlled peak, isotype Ab; open peak, CD209. (b) Infection in mDC and pDCs
rrelation of infection rates in mDC with levels of DC-SIGN expression from 7 individual
stern blot in mDC and pDC at 48 h post-viral exposure. (e) Infection determined by
12 and 24 h after DV infection from time 0 (time 0 RNA copy # were below 300 and was
Fig. 3. Cytokine production and phenotype maturation of mDCs and pDCs. mDC and pDC were infected with equal MOI of DV. (a) Supernatants were harvested at 24 and 48 h.
Cytokine were determined. Data represent 5 experiments. Error bars were SEM. (b) Cells were harvested at 48 h and co-stimulatory markers were determined by immuno-
ﬂuorescent staining. As labeled, isotype staining was shown in open line, mock-infected cells in ﬁlled peak and DV-infected cells in bold-open line. Data represent 3 experiments.
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Chloroquine N5 μg/ml completely or nearly completely inhibited IFN-
α response, whereas 10 fold less (0.5 μg/ml) chloroquine elicited
partial inhibition. Further dilution (0.05 μg/ml) of chloroquine
rendered loss of its inhibitory effect. More detailed analysis showed
that a 90% inhibition of Type I IFN could be achieved with as low as
1.25 μg/ml of chloroquine (data not shown). At day 2 of chloroquineFig. 4. Cytokine production from mDC and pDC stimulated with UV-attenuated DV. Live and
48 h were determined. Data were from 3 experiments. Error bars were SEM.treatment, wemeasured cell viability (Fig. 5b). Therewas no reduction
of viability within the chloroquine dose range of 0.05 μg/ml–5 μg/ml.
However, at a higher chloroquine concentration (10 μg/ml), cell counts
begin to decline compared to untreated cultures. We conclude that an
appropriate amount of chloroquine could abrogate pDC activity
without affecting cell viability. The results suggest that the endosomal
activity is required for pDC activation.UV-treated DV were used to infect a) mDCs, and b) pDCs. IFN-α production at 24 h and
Fig. 5. Chloroquine dose-dependent inhibition of pDC IFN production. (a) pDCwere exposed to DV in the presence of varying doses of chloroquine as indicated. At 24 and 48 h, culture
supernatants were collected and IFN-α was determined. IFN-α of Mock control was 0. (b) Viability of chloroquine treated and untreated cells. Results were from 3 separate
experiments. Error bars were SEM.
211P. Sun et al. / Virology 383 (2009) 207–215Involvement of TLR3 and TLR7 in DC subset activation
DV is a positive sensed single stranded RNA virus. During
replication, DV makes a negative stranded RNA using its genome
RNA as a template. Hence there is a temporary presence of double
stranded RNA. As ssRNA and dsRNA are known ligands for TLR7 andFig. 6. Involvement of TLR7 in pDC activation. (a) Histogram analysis of TLR7 expression on pD
CL097 (TLR7 agonist) or CpG3226 (TLR9 agonist) in the presence of IRS661 (2.8 μM) or the
stimulated pDC: pDC were exposed to DV in the presence of the inhibitors and IFN-αwas de
stimulated with DV-RNA and IFN-α was determined at 48 h. Data were from 3 experimentTLR3 respectively, we examined the possible involvement of these two
TLRs in cell activation. We did not ﬁnd signiﬁcant changes of TLR3
expression in mDC with or without DV-infection (data not shown).
However, at 48 h post-virus exposure, TLR7was signiﬁcantly increased
in DV-exposed pDC compared tomock control (Fig. 6a). The difference
on the mean ﬂuorescence intensity (MFI) of TLR7 expression betweenC at 48 h post-DV-exposure. (b) Inhibitor IRS-661 speciﬁcity: pDC were stimulated with
control ODN (2.8 μM). IFN-α production was determined. (c) IRS661 inhibition of DV-
termined at 48 h. (d) IRS661 inhibition of puriﬁed viral RNA-stimulated pDC: pDC were
s. Error bars represent SEM.
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paired student t test of 3 experiments). IRS661, an inhibitor of TLR7,
dramatically diminished IFN-α production in DV-exposed pDC while
the control ODN did not show inhibition (Fig. 6c). We isolated DV
genome RNA to stimulate pDC. As shown in Fig. 6d, pDC was able to
produce IFN-α in response to DV RNA, and this response was also
inhibited by IRS661. CpG ODN 3226 is an agonist for TLR9 and CL097 is
an agonist for TLR7. We used these two molecules as controls to show
the speciﬁcity of IRS661. IRS661 inhibited speciﬁcally the response of
CL097 but not of CpG 3226 (Fig. 6b).
Discussion
Dendritic cells are potent antigen presenting cells often targeted by
a variety of pathogens. In this study, we focused on DV infection and
immunity of two blood DC precursors, pDC and mDC. pDC, found in
the T cell area of the human lymph node, were originally named as
‘plasmacytoid monocyte’ due to their plasma cell morphology. These
cells express MHC class II, but lack the myeloid marker CD11c and the
T cell marker CD3 (Barrat et al., 2005). Identiﬁcation and isolation of
mDC and pDC from blood (Barchet et al., 2005; Cella et al., 1999; Liu,
2005; Olweus et al., 1997; Osugi et al., 2002; Robinson et al., 1999;
Wang et al., 2006) have further facilitated studies of human DC
subtypes. Based on the phenotypic difference of the two subsets, we
obtained highly puriﬁed pDC (Lin1−CD11c−CD123hi) and mDC (CD14
−CD11c+CD123med) directly from blood. Freshly isolated pDC and mDC
survived poorly ex vivo. These cells expressed low levels of CD40 and
CD86, high levels of MHC I and II, but lack expression of CD80 and
CD83. Upon cytokine treatment using well-documentedmethodology
(rIL3 for pDCs and rGM-CSF plus rIL-4 for mDCs) (Cella et al., 1999;
Hornung et al., 2004; Ito et al., 2002), both pDC and mDC underwent
phenotypic maturation and expressed all markers, CD40, CD80, CD83
and CD86 consistent with previous ﬁndings by others (Cella et al.,
1999; O'Doherty et al., 1994). In addition, DC-SIGN (CD209), a C-type
lectin critical for DV binding and internalization, was not detected on
either population when freshly isolated from blood.
The DV genome is a single-stranded messenger (positive) sense
RNA of approximately 10 kb of nucleotides encoding proteins of
membrane (M), envelope (E), and several non-structural (NS) proteins.
Monoclonal antibody 2H2, which was used for the immuno-ﬂuor-
escent staining, recognizes ﬂavivirus complex prM, a precursor of the
M protein. Using 2H2 MAb and immuno-ﬂuorescent staining, we
found that infection of mDC was positively correlated with the
induction of surface DC-SIGN expression. DC-SIGN has been demon-
strated on immatureDCs andmacrophage subpopulations abundant in
the dermis of the skin, at mucosal surface, and in lymph nodes and
peripheral tissues (Soilleux et al., 2001, 2002). Our results strength-
ened the role of DC-SIGNmolecules in rendering cell permissible to DV
infection and suggested the role of mDC as potential DV target cells.
Infection of DV was not detectable in pDC bymonoclonal antibody,
but could be detected by RT-PCR. There were relatively lower copy
numbers of negative strands in DV-exposed pDC compared to that of
mDC. Others have found DV in the endosomal compartment (Wang et
al., 2006) of pDC, suggesting that pDC are able to internalize viruses,
but are poorly supportive for viral replication. Nevertheless, pDC were
able to produce TNF-α and IFN-αwith titers 10 times higher than that
of mDC. The difference of cytokine response in mDC and pDC may be
reﬂectory of their distinctive characteristic. It is known that pDC are
capable of producing type-I IFN 100–1000 times more than other cell
types in blood (Siegal et al., 1999). It may also be reﬂective of DC-SIGN
expression which has been shown to modulate the immuno-
stimulatory function of DCs (Geijtenbeek and van Kooyk, 2003; van
Kooyk and Geijtenbeek, 2003). Co-stimulatory markers on DC surface
function to bridge DC with other lymphocytes for immune stimula-
tion. In our study, mDC, but not pDC, obtained additional upregulation
of co-stimulatory makers after DV infection, suggesting again thedisparity between mDC and pDC: mDC may function as antigen
presenting cells while pDCs the principal Type-I IFN producing cells
(Ito et al., 2005; Liu, 2005).
Attenuating DV with UV light did not affect pDC activation, while
both infection and cytokine production were diminished in mDC.
Noting that our results were different from another study in which a
complete blockage of IFN in pDC by UV-treatment of DV was reported
(Wang et al., 2006). This difference may due to different UV dosages
used. Overly inactivating or attenuating viruses either by heat
(Diebold et al., 2004) or by UV light (Wang et al., 2006) may lead to
the destruction of viral structural integrity, causing virus to lose
stimulatory properties critical for activation of pDC.
TLR, the highly conserved pattern recognition receptors, are
important molecules involved in the innate immune recognition of
pathogens, triggering a complicated series of events leading to
production of proinﬂammatory and inﬂammatory cytokines (Liu,
2005). Human pDC and mDC express very different sets of TLR: pDC
express TLR7, 8 and 9, whereasmDC express TLR1, 2, 3, 4, 5, 6, 8, and 10
(Grouard et al., 1997). TLR7 is involved in recognition of ssRNA from
RNA viruses (Cook et al., 2004; Liu, 2005). Different forms of inﬂuenza
viral antigens, live virus, heat-inactivated virus, and naked viral ssRNA,
induced strong IFN-α response through a TLR7- and MyD-88-
dependent pathway (Lund et al., 2004). TLR7 also recognizes oligo
nucleic acid PolyU, viral RNA and RNA of mammalian origin. Lund et al.
suggested that the cellular location of RNA, i.e. in endosomal
compartment, is crucial for TLR7-mediated cell activation. Two
possible mechanisms might explain the role of endosomal acidic
environment for TLR7-mediated immune activation: 1) the endoso-
mal low pH could facilitate the unfolding of viral particles for the
release of the genome RNA responsible for TLR7 binding; 2) TLR7/8-
mediated cell activation is low-PH dependent (Heil et al., 2003). In this
study, lysosomal acidiﬁcation was important for activation of pDC to
produce IFN-α in response to DV, suggesting recognition of DV occurs
in the endosomal compartment. Wang et al. showed the presence of
DV in endosomal compartments, thus supporting our observation. It
seems that the chloroquine dosage is an important factor. At
appropriate concentration, we showed that chloroquine exerted
inhibitory effect without killing cells, but the inhibitory effect
gradually diminished when chloroquine was used at suboptimal
concentration. Other groups (Wang et al., 2006) showed the
importance of endosomal low PH for pDC activation using other
chemicals, such as Balﬁlomycin. Further, we found that IFN-α
production in pDC was accompanied by an increase in TLR7
expression, and IFN-α response could be abrogated by TLR7 inhibitor
IRS661. We also showed that DV genome RNA was capable to induce
IFN-α production in pDC and this response was inhibited by TLR-7
inhibitor. Together, these results suggested the involvement of the
TLR7 in recognition of DV antigens, possibly the single stranded
genome RNA. Further studies will focus on the mechanism of TLR7
regulation and its down-stream signaling.
Detection of RNA virus also relies on TLR3-medicated recognition
of dsRNA, an intermediate product of RNA virus replication. However,
wewere unable to ﬁnd TLR3 upregulation by immuno-ﬂow cytometry
in DV-exposed mDC.We presume that the PKR pathway (Alexopoulou
et al., 2001; Vijay-Kumar et al., 2005) and the retinoic acid inducible
gene-I (RIG-I) pathway may be more important than the TLR3
pathway mainly because the TLR3 is sequestered within endosomal
compartments and may be inaccessible to dsRNA, while the PKR and
RIG are distributed in the cytosol where the dsRNA are located.
Further research into this area is our continuous interest.
In summary, this work demonstrated that DC of myeloid lineage
derived from blood mDC with rGM-CSF and rIL-4 were potential
targets for DV infection. Infected myeloid DCmay serve as a vehicle for
viral transportation to the lymph nodes where the lymphoid DC are
distributed. Blood pDC did not show a high level of infection. However,
pDC mounted a vigorous inﬂammatory cytokine response to DV. The
213P. Sun et al. / Virology 383 (2009) 207–215robust TNF-α and IFN-α response may contribute to control of viral
replication, but may also network with other cell types of the innate
immune system leading to a pathological outcome. Further, the TLR7-
dependent signaling pathways maybe one of the dominant pathways
involved in DV recognition and activation of pDC.
Material and methods
Virus preparation
DV-2 (Strain 16803, originally isolated by Halstead et al., and
maintained at the Naval Medical Research Center) was propagated in
Mycoplasma-free Vero cell lines. The viral titer was determined by
limiting dilution plaque assays on Vero cells. The presence of
contaminating lipopolysaccharide in the virus stock and culture
supernatants was evaluated by the Limulus Amebocyte Lysate test
(BioWhittaker Cambrex Inc., Walkersville, MD). Mycoplasma contam-
ination of the virus stocks and culture supernatants was evaluated by
the Mycoplasma Rapid Detection System (Gen-Probe, San Diego, CA).
All virus stocks and culture supernatants used in the present study
were free of lipopolysaccharide and mycoplasma. Virus attenuation
was achieved by treating aliquots of DV in Eppendorf tubes with ultra
violet (UV) light for 200,000 microjoules (μJ) in a UV Cross Linker
(Hoefer Scientiﬁc Instrument) by adapting published methods
(Hornung et al., 2004; Pollara et al., 2004). Supernatants harvested
from un-infected Vero cell cultures were used as mock-control.
Magnetic sorting of pDC and mDC
Whole blood units from normal, healthy, dengue-seronegative,
consenting and de-identiﬁed donors were obtained from American
Red Cross under the NMRC Project #19 and fromWRAIR Protocol #837
Project #18. PBMCs were enriched by Ficoll-Hypaque gradient
centrifugation. mDC and pDC in PBMC were isolated using Blood
Dendritic Cell Separation Kits supplemented with monoclonal anti-
body to CD1c (BDCA-1) or CD304 (BDCA-4) coupled to microbeads
(Miltenyi Biotec) as described elsewhere (Barchet et al., 2005). Brieﬂy,
according to themanufacturer's instruction, whole PBMCwere labeled
with BDCA-4 coupledmagnetic beads, and the labeled cells containing
mainly BDCA-4+ cells were sorted using a magnetic column. Isolation
of mDC from whole PBMC required depletion of CD19+ cells using
CD19-microbeads. After depletion of CD19+ cells, PBMC were labeled
with BDCA-1 microbeads, and sorted on a magnetic column. This
process yielded N90% purity of BDCA4+ cells expressing pDC
phenotype Lin1−CD11c−CD123high and N90% of BDCA-1+ cells expres-
sing mDC phenotype Lin1−CD11c+CD14−CD123med.
Infection of mDC and pDC
All cell cultures were maintained in RPMI 1640 media supple-
mented with 1% L-glutamine, 1% penicillin/streptomycin, 1% essential
amino acids, and 10% heat inactivated fetal bovine serum (FBS) (all
from GIBCO BRL, Gaithersburg, MD). All cytokines (R&D system) were
used at the concentration of 20 ng/ml. pDC were infected with DV in
the presence of rIL-3, while freshly isolated mDC were ﬁrst treated
with rGM-CSF and rIL-4 for 2 days and then exposed to DV. mDC and
pDC were infected with live or UV-treated DV at multiplicities of
infection (MOI) of 10 and cultured at a density of 5×105 cells/ml at
37 °C in a 5% CO2 atmosphere. Cells and culture supernatants were
harvested at indicated culture periods (24 h or 48 h) for use in assays
described below.
Cell surface marker
To measure cell surface expression of co-stimulatory and HLA
molecules, cells were stained with PE-conjugated monoclonal anti-bodies to CD40 and CD83 (Coulter Immunotech, FL), CD80 (clone
L307.4), CD86 (clone IT2.2), HLA-ABC (clone G46-2.6), and HLA-DR
(clone G46-6), and CD209 (BD Pharmingen, San Diego, CA). Isotype
controls, mouse IgG1 (clone MOPC-21C) and mouse IgG2b (clone 27–
35) (BD Pharmingen), were included in each experiment.
Detection of virus intracellularly and in cell lysate by antibodies
DV-exposed cell cultures were ﬁxed and permeabilized with
Cytoﬁx and CytoPerm (BD Pharmingen) according to the manufac-
turer's recommendation, then stained with FITC-2H2, a monoclonal
antibody speciﬁc for a precursor of DV membrane protein prM
synthesized during viral replication. FITC-labeled samples were
acquired on a FACScan ﬂow cytometer (BD Pharmingen) and analyzed
using Cell Quest software. For Western blot, DV-exposed and
unexposed cells were collected in 1.5 ml centrifuge tubes and washed
twice after 2 days of infection. Cell pellets were resuspended in 20 ml
of lysis buffer containing SDS and 2-mercaptoethanol. The lysates
were electrophoresed by SDS-PAGE and the separated proteins were
transferred onto nitrocellulose membranes and subjected to Western
blot analyses. Membranes were probed with anti-DV-2 immune
ascites ﬂuid (a generous gift of Ms. M. Simmons, Naval Medical
Research Center, Silver Spring, MD) followed by an Horse Radish
Peroxide (HRP)-conjugated secondary antibody. Bands were visua-
lized using SuperSignal Chemo-luminescence substrate from Pierce
(Rockford, IL).
Quantiﬁcation of negative-sense dengue RNA
A Real Time-Polymerase Chain Reaction (RT-PCR) assay was
developed to quantify negative-sense dengue RNA, an intermediate
RNA formed during viral replication. Dengue RNA standards were
generated as described previously (Boonnak et al., 2008). The in vitro
transcribed negative sense RNA was generated by T7 transcription
(Promega,Medison,WI) of SpeI linearized capsid-pGem/T-easy plasmid.
Total RNA was extracted from 104 cells using an RNeasy mini kit
(QIAGEN, Valencia, CA). Aliquots (5 μl) of total RNA isolated fromdengue
exposed cells and a known amount of negative sense dengue RNA
standard (log fold dilution range: 102–107 copies) were subjected to an
RT using sense primers (5′-GCTGAAACGCGAGAGAAACC-3′) and a
superscript III cDNA synthesis kit (Invitrogen, Carlsbad, CA) to quantitate
negative-sense dengue RNA. Real time PCR assays were carried out in
triplicate using an ABI Prism 7500 sequence detector instrument
(Applied Biosystems, Foster City, CA). An aliquot of cDNA (5 μl) was
subjected to the thermal cycleusingprimers, probeandPCR core reagent
kit (Applied Biosystems) as described previously (Boonnak et al., 2008).
The ampliﬁcation conditionswere 40 cycles of 95 °C for 15 s and60 °C for
1 min. Intracellular negative strand dengue RNA was calculated by
dividing the copy number of negative sense RNA by the number of cells.
Cytokine production
IFN-α was measured by ELISA according to the manufacturer's
recommendations (PBL Biomedical Labs, Piscataway, NJ). Samples
were read on a SpectraMax 340 plate reader (Molecular Devices Corp.,
Sunnyvale, CA). All other cytokines were quantiﬁed by cytometric
bead array (CBA) using the Inﬂammation CBA kit, on a FACScan using
the CBA software (BD Pharmingen). The Inﬂammation CBA kit allows
measurement of IL-12p70, TNF-α, IL-10, IL-6, IL-8, IL-1β.
Alteration of endosomal acidiﬁcation in pDCs
Chloroquine Diphosphate (C18H26ClN3.2H3PO4) (Department of
Chemical Information, Walter Reed Army Institute of Research) was
used at the indicated concentration andwas added at the beginning of
the cell culture. Cell counting and viability measurement was
214 P. Sun et al. / Virology 383 (2009) 207–215performed using Guava Viacount Reagent and Cytosoft 2.1.4 (Guava
Technologies, Inc. Hayward, CA).
Immunoﬂuorescent staining for TLRs
Rabbit anti-TLR7 unconjugated polyclonal antibody and goat anti-
rabbit IgG (H+L) PE-conjugated secondary antibody (Imgenex, San
Diego, CA) were used to measure the expression of TLR7 in ﬁxed and
permeabilized pDC. Rabbit IgG isotype control (Imgenex) was
included in the assay.
FITC labeled anti-TLR3 monoclonal antibody (clone 40C1285.6)
(Imgenex, San Diego, CA) was used to measure TLR3 expression in
ﬁxed and permeabilized mDC. Mouse IgG1-FITC isotype control (BD
Pharmingen) was included in the assay.
RNA puriﬁcation and transfection
Brieﬂy, 7% Polyethylene Glycol and 2.3% NaCl was added to 500 ml
of supernatant containing viruses and allowed to mix at 4 °C
overnight. The solution was centrifuged at 8000 rpm in a Sorvall
RC5C for 30 min. The pellet was washed with 10 ml of TSE (Tris,
Sodium Chloride, EDTA), then resuspended in 5 ml of TSE. RNA was
extracted with Qiagen Viral RNA isolation kit, using 140 μl of
resuspended solution per extraction and eluted in 60 μl of elution
buffer. RNA transfection was performed using Lipofectamine™ 2000
(Invitrogen) following the manufacturer's instruction. Brieﬂy, 0.5 μl
Lipofectamine™ 2000 was gently diluted in 50 μl Opti-MEM I reduced
Serum Medium (Invitrogen) without serum. After 5 min in room
temperature, 2.4 μg DV RNA or equal volume of deionized H2O used as
control was added to diluted Lipofectamine by gentle mixing. After
20min in room temperature,100 μl of pDCwasmixed gently with RNA
and the culture was kept in the 37 °C, 5% CO2 incubator for the
indicated period.
TLR ligands and inhibitors
Oligodeoxynucleotide (ODN)-based TLR inhibitors used in this
study included TLR7 inhibitor IRS661: 5′-TGCTTGCAAGCTTG-
CAAGCA-3′; and the control ODN: 5′-TCCTGCAGGTTAAGT-3′. All
ODN were phosphorothioate (Integrated DNA Technologies) and
were used at 2.8 μM. TLR ligands included the imidazoquinoline
compound CL097 (Invivogen) for TLR7/8 and ODN2336 for TLR9
(Coley Pharmaceuticals).
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